148 related articles for article (PubMed ID: 29323547)
21. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing enhancing from nonenhancing renal lesions with fast kilovoltage-switching dual-energy CT.
Kaza RK; Caoili EM; Cohan RH; Platt JF
AJR Am J Roentgenol; 2011 Dec; 197(6):1375-81. PubMed ID: 22109292
[TBL] [Abstract][Full Text] [Related]
23. The Value of Nonenhanced Single-Source Dual-Energy CT for Differentiating Metastases From Adenoma in Adrenal Glands.
Ju Y; Liu A; Dong Y; Liu Y; Wang H; Sun M; Pu R; Chen A
Acad Radiol; 2015 Jul; 22(7):834-9. PubMed ID: 25957502
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
25. CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis.
Avila NA; Dwyer AJ; Rabel A; Darling T; Hong CH; Moss J
Radiology; 2010 Mar; 254(3):851-7. PubMed ID: 20177097
[TBL] [Abstract][Full Text] [Related]
26. Renal cell carcinoma: attenuation values on unenhanced CT.
Pooler BD; Pickhardt PJ; O'Connor SD; Bruce RJ; Patel SR; Nakada SY
AJR Am J Roentgenol; 2012 May; 198(5):1115-20. PubMed ID: 22528901
[TBL] [Abstract][Full Text] [Related]
27. Effect of Model-Based Iterative Reconstruction on CT Number Measurements Within Small (10-29 mm) Low-Attenuation Renal Masses.
Shampain KL; Davenport MS; Cohan RH; Goodsitt MM; Ellis JH; Platt JF
AJR Am J Roentgenol; 2015 Jul; 205(1):85-9. PubMed ID: 26102384
[TBL] [Abstract][Full Text] [Related]
28. Pleural effusion: characterization with CT attenuation values and CT appearance.
Abramowitz Y; Simanovsky N; Goldstein MS; Hiller N
AJR Am J Roentgenol; 2009 Mar; 192(3):618-23. PubMed ID: 19234255
[TBL] [Abstract][Full Text] [Related]
29. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy.
Leffler SG; Chew FS
AJR Am J Roentgenol; 1999 May; 172(5):1389-92. PubMed ID: 10227522
[TBL] [Abstract][Full Text] [Related]
30. Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?
Vassiliou V; Kalogeropoulou C; Petsas T; Leotsinidis M; Kardamakis D
Clin Exp Metastasis; 2007; 24(1):49-56. PubMed ID: 17295093
[TBL] [Abstract][Full Text] [Related]
31. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.
Foerster R; Eisele C; Bruckner T; Bostel T; Schlampp I; Wolf R; Debus J; Rief H
Radiat Oncol; 2015 Mar; 10():62. PubMed ID: 25884703
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma attenuation values on unenhanced CT: importance of multiple, small region-of-interest measurements.
McGahan JP; Sidhar K; Fananapazir G; Early H; Corwin MT; Silverman SG; Seibert A
Abdom Radiol (NY); 2017 Sep; 42(9):2325-2333. PubMed ID: 28389785
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic yield of percutaneous biopsy for sclerotic bone lesions: Influence of mean Hounsfield units.
Ní Mhuircheartaigh J; McMahon C; Lin YC; Wu J
Clin Imaging; 2017; 46():53-56. PubMed ID: 28728015
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced CT of the abdomen to predict clinical prognosis in patients with hypovolemic shock.
Kanki A; Ito K; Tamada T; Higashi H; Sato T; Tanimoto D; Higaki A
AJR Am J Roentgenol; 2011 Dec; 197(6):W980-4. PubMed ID: 22109343
[TBL] [Abstract][Full Text] [Related]
35. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
[TBL] [Abstract][Full Text] [Related]
37. Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
Pickhardt PJ; Lauder T; Pooler BD; Muñoz Del Rio A; Rosas H; Bruce RJ; Binkley N
Osteoporos Int; 2016 Jan; 27(1):147-52. PubMed ID: 26153046
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
Halefoglu AM; Bas N; Yasar A; Basak M
Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
[TBL] [Abstract][Full Text] [Related]
39. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values?
Ho LM; Marin D; Neville AM; Barnhart HX; Gupta RT; Paulson EK; Boll DT
AJR Am J Roentgenol; 2012 Apr; 198(4):840-5. PubMed ID: 22451549
[TBL] [Abstract][Full Text] [Related]
40. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
